Archive | ARTES Biotechnology GmbH

Home / Archive

ARTES White Paper outlines high-yield production process for secreted and active Invertase

Tuesday 15th August 2017

By ARTES Biotechnology… Learn More >

Cell line development based on efficient high-yield microbial expression platforms

Monday 3rd July 2017

By ARTES Biotechnology… Learn More >

BioSimilars – Technology Transfer

Tuesday 23rd May 2017

By ARTES Biotechnology… Learn More >

METAVAX® – Proprietary Innovative Vaccine Platform

Wednesday 10th May 2017

By ARTES Biotechnology… Learn More >

ARTES enters Animal Health Investment Dragons Den

Monday 13th February 2017

By ARTES Biotechnology… Learn More >

ARTES in co-development deal for HPV vaccine

Monday 30th January 2017

By ARTES Biotechnology… Learn More >

ARTES in partnership to develop novel hepatitis C vaccine

Friday 5th August 2016

By ARTES Biotechnology… Learn More >

ARTES Biotechnology joins forces with Italy’s Biosphere

Friday 24th June 2016

By ARTES Biotechnology… Learn More >

ARTES fast tracks new plant to manufacture multi-gram preclinical samples

Tuesday 29th March 2016

By ARTES Biotechnology… Learn More >

ARTES to exhibit at DBT 2015 Cologne

Tuesday 21st April 2015

By ARTES Biotechnology… Learn More >

ARTES Biotechnology and Boehringer Ingelheim Animal Health Announce Collaboration

Thursday 19th March 2015

By ARTES Biotechnology… Learn More >

ARTES partners with Burnet Institute to develop malaria transmission blocker

Thursday 14th August 2014

By ARTES Biotechnology… Learn More >